Canada: Medical lab chains will combine forces, big bills to come for government
The Competition Bureau has announced that it will not take action to block two of British Columbia’s largest private medical chains from merging. LifeLabs plans to guy BC Biomedical, an acquisition that will mean LifeLab will now bill nearly $200 million a year to the government’s Medical Service Plan for state-funded testing. Despite concerns over the merger, the Medical Services Commission has reportedly approved for LifeLabs to run the former BC Biomedical labs. The parties expect to close the deal in April.
Featured News
DOJ Considers Reviving Collaboration Guidelines to Clarify Antitrust Rules
Mar 25, 2026 by
CPI
JetBlue Weighs Sale to Rival Airlines Amid Strategic Review
Mar 25, 2026 by
CPI
Chile Approves Joint Codelco–Anglo American Copper Project
Mar 25, 2026 by
CPI
Bernie Sanders Unveils Bill to Ban Data Centers Until Congress Passes AI Regulation
Mar 25, 2026 by
CPI
CFTC Unveils New Task Force to Focus on AI, Crypto, Prediction Markets
Mar 25, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers